BioCentury
ARTICLE | Financial News

French allergy company DBV planning IPO

February 1, 2012 1:29 AM UTC

DBV Technologies (Bagneux, France) is planning an IPO on Euronext Paris. DBV is developing allergy treatments using its Viaskin technology to deliver proteins epicutaneously. DBV's Viaskin Peanut is i...